Department of Pediatric Surgery, Medical and Dental Sciences Area, Research and Education Assembly, Research Field in Medicine and Health Sciences, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima City, Kagoshima, 890-8520, Japan.
Department of Pediatric Surgery, Kagoshima City Hospital, Kagoshima, Japan.
Pediatr Surg Int. 2023 Feb 15;39(1):125. doi: 10.1007/s00383-023-05420-2.
Management of persistently patent ductus arteriosus (PDA) in extremely low-birth-weight infants (ELBWIs) requires attention due to the risk of tissue hypoperfusion. We investigated the association between PDA and gastrointestinal perforation.
We performed a retrospective chart review from 2012 to 2021. Preterm (≤ 32 weeks) ELBWIs with PDA after birth who developed necrotizing enterocolitis (NEC), focal intestinal perforation (FIP), and idiopathic gastric perforation were included; ELBWIs with congenital heart disease were excluded. Data were analyzed using chi-squared tests with Yates; correction, and Student's t test.
Five hundred thirty-five preterm ELBWIs were analyzed, including 20 with NEC, 22 with FIP, and 1 with gastric perforation. In NEC and FIP, the ductus arteriosus remained open in 40% (4/10) and 63.6% (14/22) of cases, respectively, and cyclo-oxygenase inhibitor treatment showed poor efficacy (p = 0.492 and 0.240). The incidence of perforation in NEC (4/9 vs. 6/11, p = 0.653), mortality in NEC (3/4 vs. 3/6, p = 0.895) and FIP (6/14 vs. 3/8, p = 0.838) did not differ according to whether the PDA persisted or resolved.
The presentation of PDA did not affect the mortality or morbidity of ELBWIs. However, it is essential to consider the possibility of gastrointestinal perforation due to decreased organ blood flow caused by ductal steal.
由于组织灌注不足的风险,极早产儿(ELBWIs)持续性动脉导管未闭(PDA)的管理需要引起重视。我们研究了 PDA 与胃肠穿孔之间的关系。
我们对 2012 年至 2021 年进行了回顾性图表审查。纳入出生后发生坏死性小肠结肠炎(NEC)、局灶性肠穿孔(FIP)和特发性胃穿孔的早产儿(≤32 周)ELBWIs 伴 PDA;排除患有先天性心脏病的 ELBWIs。使用 Yates 校正的卡方检验和学生 t 检验进行数据分析。
共分析了 535 例早产儿 ELBWIs,其中 NEC 20 例,FIP22 例,胃穿孔 1 例。在 NEC 和 FIP 中,动脉导管分别在 40%(4/10)和 63.6%(14/22)的病例中持续开放,环氧化酶抑制剂治疗效果不佳(p=0.492 和 0.240)。NEC(4/9 与 6/11,p=0.653)和 FIP(6/14 与 3/8,p=0.838)穿孔发生率、NEC 死亡率(3/4 与 3/6,p=0.895)和 FIP 死亡率(6/14 与 3/8,p=0.838)均不受 PDA 持续或缓解的影响。
PDA 的表现并未影响 ELBWIs 的死亡率或发病率。然而,由于导管窃取导致器官血液减少,必须考虑胃肠穿孔的可能性。